{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "gyZ1sea-gtMV",
        "outputId": "4c8448c2-591e-44fd-d2a0-49f3bd921aa8"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: transformers in /usr/local/lib/python3.11/dist-packages (4.48.3)\n",
            "Collecting faiss-cpu\n",
            "  Downloading faiss_cpu-1.11.0-cp311-cp311-manylinux_2_28_x86_64.whl.metadata (4.8 kB)\n",
            "Requirement already satisfied: openai in /usr/local/lib/python3.11/dist-packages (1.61.1)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.11/dist-packages (from transformers) (3.17.0)\n",
            "Requirement already satisfied: huggingface-hub<1.0,>=0.24.0 in /usr/local/lib/python3.11/dist-packages (from transformers) (0.28.1)\n",
            "Requirement already satisfied: numpy>=1.17 in /usr/local/lib/python3.11/dist-packages (from transformers) (1.26.4)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.11/dist-packages (from transformers) (24.2)\n",
            "Requirement already satisfied: pyyaml>=5.1 in /usr/local/lib/python3.11/dist-packages (from transformers) (6.0.2)\n",
            "Requirement already satisfied: regex!=2019.12.17 in /usr/local/lib/python3.11/dist-packages (from transformers) (2024.11.6)\n",
            "Requirement already satisfied: requests in /usr/local/lib/python3.11/dist-packages (from transformers) (2.32.3)\n",
            "Requirement already satisfied: tokenizers<0.22,>=0.21 in /usr/local/lib/python3.11/dist-packages (from transformers) (0.21.0)\n",
            "Requirement already satisfied: safetensors>=0.4.1 in /usr/local/lib/python3.11/dist-packages (from transformers) (0.5.3)\n",
            "Requirement already satisfied: tqdm>=4.27 in /usr/local/lib/python3.11/dist-packages (from transformers) (4.67.1)\n",
            "Requirement already satisfied: anyio<5,>=3.5.0 in /usr/local/lib/python3.11/dist-packages (from openai) (3.7.1)\n",
            "Requirement already satisfied: distro<2,>=1.7.0 in /usr/local/lib/python3.11/dist-packages (from openai) (1.9.0)\n",
            "Requirement already satisfied: httpx<1,>=0.23.0 in /usr/local/lib/python3.11/dist-packages (from openai) (0.28.1)\n",
            "Requirement already satisfied: jiter<1,>=0.4.0 in /usr/local/lib/python3.11/dist-packages (from openai) (0.8.2)\n",
            "Requirement already satisfied: pydantic<3,>=1.9.0 in /usr/local/lib/python3.11/dist-packages (from openai) (2.10.6)\n",
            "Requirement already satisfied: sniffio in /usr/local/lib/python3.11/dist-packages (from openai) (1.3.1)\n",
            "Requirement already satisfied: typing-extensions<5,>=4.11 in /usr/local/lib/python3.11/dist-packages (from openai) (4.12.2)\n",
            "Requirement already satisfied: idna>=2.8 in /usr/local/lib/python3.11/dist-packages (from anyio<5,>=3.5.0->openai) (3.10)\n",
            "Requirement already satisfied: certifi in /usr/local/lib/python3.11/dist-packages (from httpx<1,>=0.23.0->openai) (2025.1.31)\n",
            "Requirement already satisfied: httpcore==1.* in /usr/local/lib/python3.11/dist-packages (from httpx<1,>=0.23.0->openai) (1.0.7)\n",
            "Requirement already satisfied: h11<0.15,>=0.13 in /usr/local/lib/python3.11/dist-packages (from httpcore==1.*->httpx<1,>=0.23.0->openai) (0.14.0)\n",
            "Requirement already satisfied: fsspec>=2023.5.0 in /usr/local/lib/python3.11/dist-packages (from huggingface-hub<1.0,>=0.24.0->transformers) (2024.10.0)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.11/dist-packages (from pydantic<3,>=1.9.0->openai) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.27.2 in /usr/local/lib/python3.11/dist-packages (from pydantic<3,>=1.9.0->openai) (2.27.2)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.11/dist-packages (from requests->transformers) (3.4.1)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.11/dist-packages (from requests->transformers) (2.3.0)\n",
            "Downloading faiss_cpu-1.11.0-cp311-cp311-manylinux_2_28_x86_64.whl (31.3 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m31.3/31.3 MB\u001b[0m \u001b[31m77.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: faiss-cpu\n",
            "Successfully installed faiss-cpu-1.11.0\n"
          ]
        }
      ],
      "source": [
        "!pip install transformers faiss-cpu openai"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "vweNowAaj7Ra",
        "outputId": "c24a7711-7093-42da-b6a2-9eae1848eae5"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "✅ Loaded cached vectors.\n",
            "\n",
            "🟦 QUESTION 1: I have a patient who can’t take lithium but is currently acutely manic. Which medication should I try next?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "No clear recommendation found in the manual.\n",
            "\n",
            "🟦 QUESTION 2: My patient with BDI-Depression had side effects from quetiapine. Which medication should I try next?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "For a patient with BDI-Depression who experienced side effects from quetiapine, considering an alternative serotonin-dopamine activity modulator with a more favorable side effect profile is advisable. Aripiprazole and brexpiprazole are recommended as first-line agents due to their efficacy and tolerability, making them suitable options to try next. These medications have a lower risk of sedation and metabolic side effects compared to quetiapine, which may improve the patient's overall treatment experience.\n",
            "\n",
            "🟦 QUESTION 3: I have a patient experiencing hypomania and symptoms of depression. What is the recommended treatment?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "For a patient experiencing hypomania and symptoms of depression, which may be indicative of an MDE (Major depressive episode) with mixed features, the CANMAT guidelines recommend managing such cases in consultation with a psychiatrist due to the complexity of differentiating them from bipolar disorders. First-line antidepressants are still recommended, but close monitoring for activating side effects and potential manic/hypomanic switch is essential. Additionally, lurasidone, a serotonin-dopamine activity modulator, is recommended as a second-line agent due to evidence of efficacy in this context (Section: Question 3. How are Treatments Selected? > Q.3.g. How do DSM-5-TR Specifiers and Symptom Dimensions Influence Medication Selection?).\n",
            "\n",
            "🟦 QUESTION 4: My patient with Bipolar II disorder is acutely depressed. What medication should I try?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "For a patient with Bipolar II disorder experiencing an acute depressive episode, lamotrigine is a recommended option as it is frequently used for bipolar depression. However, it is important to initiate treatment at low doses and titrate gradually due to the risk of Stevens–Johnson Syndrome, a severe allergic reaction. While lamotrigine is noted for its tolerability, it is considered a third-line adjunctive agent, so it may be used when other first-line treatments are not effective or suitable.\n",
            "\n",
            "🟦 QUESTION 5: My patient with BDII will not adhere to any treatment plan that causes weight gain. How should I treat his depression?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "In treating a patient with BDII (Bipolar II Disorder) who is concerned about weight gain, it is important to consider medications and treatments that have a lower risk of this side effect. The CANMAT guidelines suggest regular monitoring of weight, glucose, and lipid profiles for patients on medications associated with weight gain, indicating the importance of selecting treatments with minimal impact on weight. Additionally, the guidelines emphasize a personalized care approach that incorporates patient preferences, suggesting that shared decision-making is crucial. Therefore, consider psychological treatments like CBT (Cognitive-behavioral therapy) as an adjunctive option, as it does not contribute to weight gain and has evidence supporting its efficacy in reducing depressive symptoms.\n",
            "\n",
            "🟦 QUESTION 6: My patient responded well to divalproex for acute mania in the past, but is now pregnant. How should I treat her?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "No clear recommendation found in the manual.\n",
            "\n",
            "🟦 QUESTION 7: My patient with Type 1 Bipolar and comorbid diabetes is experiencing depression. What is the recommended treatment?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "For a patient with Type 1 Bipolar Disorder and comorbid diabetes experiencing depression, the CANMAT guidelines suggest that antidepressants remain indicated for treating major depressive disorder with comorbidities, as they have been shown to be more efficacious than placebo across a range of medical conditions, including diabetes (Section: Q.3.n. How are Comorbid Conditions Managed?). However, given the bipolar context, lamotrigine, a glutamate modulator, is frequently used for bipolar depression and may be considered as an adjunctive treatment, though it is recommended as a third-line agent due to the risk of Stevens–Johnson Syndrome and the need for careful dose titration (Section: Q.7.g. What are the Risks and Benefits of Specific Adjunctive Medications?). It is important to collaborate with the patient to consider their preferences and treatment history when selecting the most appropriate treatment plan.\n",
            "\n",
            "🟦 QUESTION 8: My patient has hepatic dysfunction and is hypomanic. What is the recommended treatment?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "For a patient with hepatic dysfunction and hypomania, careful consideration of medication safety is crucial. According to the CANMAT guidelines, antidepressants such as agomelatine, bupropion, duloxetine, and nefazodone are associated with a higher risk of adverse liver effects and should be used cautiously in patients with liver issues. Citalopram and escitalopram have a lower risk of liver injury, making them potentially safer options for patients with hepatic dysfunction. However, given the presence of hypomania, it is important to assess for bipolar disorder, as antidepressants alone may exacerbate manic symptoms. In such cases, mood stabilizers or atypical antipsychotics may be more appropriate, but specific recommendations for these medications in the context of hepatic dysfunction are not provided in the manual. Therefore, consulting a specialist for personalized treatment planning is advisable.\n",
            "\n",
            "🟦 QUESTION 9: My patient with Type 1 Bipolar and cardiovascular disease is experiencing depression. What is the recommended treatment?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "The CANMAT guidelines indicate that antidepressants are efficacious for treating major depressive disorder (MDD) even in the presence of comorbid medical conditions, such as cardiovascular disease. However, since your patient has Type 1 Bipolar Disorder, it is important to note that the guidelines for bipolar disorder are separate and were developed in collaboration with the International Society for Bipolar Disorders (ISBD). For bipolar depression, mood stabilizers or atypical antipsychotics are typically preferred over antidepressants to avoid triggering manic episodes. Therefore, it would be advisable to refer to the specific CANMAT guidelines for bipolar disorder for a more tailored treatment approach.\n",
            "\n",
            "🟦 QUESTION 10: I have a Bipolar Type II patient with renal disease who is experiencing depression. What is the recommended treatment?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "No clear recommendation found in the manual.\n",
            "\n",
            "🟦 QUESTION 11: My patient is experiencing their fourth episode of mania this year. How should I proceed?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "No clear recommendation found in the manual.\n",
            "\n",
            "🟦 QUESTION 12: I have a patient who is manic and experiencing psychotic features. I am considering the possibility of schizoaffective disorder. How should I proceed?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "For a patient presenting with manic and psychotic features, it is crucial to consider the possibility of schizoaffective disorder. According to the CANMAT guidelines, in cases of severe major depressive episodes with psychotic symptoms, the combination of an antidepressant and an atypical antipsychotic (serotonin-dopamine activity modulator) is recommended. However, given the manic presentation, it is important to consult with a psychiatrist for accurate diagnosis and management, as differentiating between schizoaffective disorder and other conditions like bipolar disorder with psychotic features can be complex. Structured psychotherapy should be deferred until psychotic symptoms are managed.\n",
            "\n",
            "🟦 QUESTION 13: My patient is currently acutely depressed. He takes quetiapine for anti-manic prophylaxis, but it doesn't work for his depression. What should I try next?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "In cases where a patient with difficult-to-treat depression (DTD) is not responding well to their current treatment, adjunctive treatment with serotonin-dopamine activity modulators, such as atypical antipsychotics, is recommended. Aripiprazole and brexpiprazole are first-line adjunctive agents due to their efficacy and tolerability profile. If quetiapine is not effective for the depressive symptoms, considering switching to one of these first-line agents could be beneficial. Additionally, it is important to balance the potential side effects, such as akathisia and weight gain, with the expected benefits when making this decision.\n",
            "\n",
            "🟦 QUESTION 14: My patient needs a quick treatment for their depression as they have pronounced suicidality. What should we use?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "For a patient with pronounced suicidality, CANMAT guidelines suggest considering electroconvulsive therapy (ECT) as a first-choice option in severe cases of major depressive episodes (MDE) with high suicide risk (Section: Q.3.a. How is the Initial Treatment Selected?). Additionally, inpatient treatment is often warranted for high-risk patients to ensure safety and provide timely pharmacological and nonpharmacological interventions (Section: Q.2.c. How are Suicide and Safety Risks Managed?). Enhanced monitoring and safety planning are crucial during the initial treatment period, especially when starting or stopping antidepressants (Section: Q.3.h. Are Antidepressants Associated With an Increased Risk of Suicide?).\n",
            "\n",
            "🟦 QUESTION 15: My patient with bipolar II responded well to lamotrigine in the past for acute depression. However, he was just admitted due to significant active suicidal ideation which I would like to treat as soon as possible. What should we use?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "In cases of severe major depressive episodes with high suicide risk, such as your patient with bipolar II and significant active suicidal ideation, CANMAT recommends considering electroconvulsive therapy (ECT) as a first-choice option due to its rapid efficacy (Section: Q.3.a. How is the Initial Treatment Selected?). While lamotrigine has been effective for your patient in the past, it is primarily recommended as a third-line adjunctive agent and may not provide the immediate response needed in life-threatening situations. Additionally, inpatient treatment is often warranted for high-risk patients to ensure safety and close monitoring (Section: Q.2.c. How are Suicide and Safety Risks Managed?).\n",
            "\n",
            "🟦 QUESTION 16: My patient is experiencing acute depression with anxious distress. Which first-line treatment should I choose?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "For a patient experiencing acute depression with anxious distress, CANMAT guidelines recommend using any first-line antidepressants, as there is no specific medication shown to have superior efficacy for anxious distress. The choice should be made collaboratively with the patient, considering their preferences and any past treatment responses. Additionally, structured psychotherapy, such as CBT, can be considered as it is effective for MDD and may help address anxiety symptoms. Combining antidepressant medication with psychotherapy is also an option to enhance treatment efficacy.\n",
            "\n",
            "🟦 QUESTION 17: I treated my patient's acute mania with lithium. How should I proceed with maintenance treatment?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "For maintenance treatment following acute mania, lithium remains a viable option, especially given its efficacy in preventing recurrence. The CANMAT guidelines suggest that lithium, when combined with either nortriptyline or venlafaxine-XR, is superior for relapse prevention compared to using either antidepressant alone. It is important to monitor serum lithium levels regularly to ensure therapeutic efficacy and minimize potential side effects. Additionally, consider patient-specific factors such as previous treatment responses and preferences when deciding on maintenance strategies.\n",
            "\n",
            "🟦 QUESTION 18: I treated my patient's acute depression with quetiapine. How should I proceed with maintenance treatment?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "For maintenance treatment following acute depression remission with quetiapine, the CANMAT guidelines suggest continuing maintenance pharmacotherapy to prevent recurrence. Maintenance medication treatment, including atypical antipsychotics like quetiapine, can significantly reduce relapse rates. It is recommended to maintain the treatment for 6 to 12 months after achieving symptomatic remission, as extending maintenance treatment provides additional benefits compared to stopping earlier. Additionally, flexible dose adjustments are more effective than fixed doses, so consider adjusting the dose as needed based on the patient's response and tolerability.\n",
            "\n",
            "🟦 QUESTION 19: What is the recommended maintenance treatment for my patient with BDII, if depression was treated with quetiapine?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "No clear recommendation found in the manual.\n",
            "\n",
            "🟦 QUESTION 20: I'm about to start treating a patient with lithium, what are common side effects at the start?\n",
            "\n",
            "🤖 GPT-4o Answer:\n",
            "The CANMAT clinical manual does not provide specific details on the common side effects of lithium at the start of treatment. However, it notes that lithium requires serum level monitoring due to its narrow therapeutic index and potential for toxicity. It is important to monitor thyroid levels as well, given lithium's potential impact on thyroid function. For more detailed information on side effects, it would be advisable to consult additional resources or clinical guidelines specific to lithium treatment.\n"
          ]
        }
      ],
      "source": [
        "# -*- coding: utf-8 -*-\n",
        "import os, json, hashlib\n",
        "import numpy as np\n",
        "import faiss\n",
        "from transformers import AutoTokenizer, AutoModel\n",
        "import torch\n",
        "from openai import OpenAI\n",
        "\n",
        "# ✅ Initialize OpenAI client (use API key directly or environment variable)\n",
        "client = OpenAI(api_key=\"\")  # <- Replace with your GPT-4o API Key\n",
        "\n",
        "# ✅ Load document chunks\n",
        "with open(\"output.json\", \"r\", encoding=\"utf-8\") as f:\n",
        "    chunks = json.load(f)\n",
        "\n",
        "# ✅ Compute MD5 for cache control\n",
        "def compute_md5(file_path):\n",
        "    with open(file_path, \"rb\") as f:\n",
        "        return hashlib.md5(f.read()).hexdigest()\n",
        "\n",
        "json_md5 = compute_md5(\"output.json\")\n",
        "\n",
        "# ✅ Load embedding model (bge-large-en-v1.5)\n",
        "tokenizer = AutoTokenizer.from_pretrained(\"BAAI/bge-large-en-v1.5\")\n",
        "model = AutoModel.from_pretrained(\"BAAI/bge-large-en-v1.5\")\n",
        "model.eval()\n",
        "\n",
        "# ✅ Convert text to embedding\n",
        "def get_embedding(text):\n",
        "    encoded_input = tokenizer(\"query: \" + text, return_tensors='pt', max_length=512, truncation=True)\n",
        "    with torch.no_grad():\n",
        "        model_output = model(**encoded_input)\n",
        "    token_embeddings = model_output.last_hidden_state\n",
        "    attention_mask = encoded_input['attention_mask']\n",
        "    input_mask_expanded = attention_mask.unsqueeze(-1).expand(token_embeddings.size()).float()\n",
        "    sum_embeddings = torch.sum(token_embeddings * input_mask_expanded, dim=1)\n",
        "    sum_mask = torch.clamp(input_mask_expanded.sum(dim=1), min=1e-9)\n",
        "    mean_pooled = sum_embeddings / sum_mask\n",
        "    return mean_pooled.squeeze().numpy()\n",
        "\n",
        "# ✅ Embed document chunks in batch\n",
        "def embed_chunks(chunks):\n",
        "    return np.array([get_embedding(c[\"text\"]) for c in chunks])\n",
        "\n",
        "# ✅ Caching mechanism\n",
        "if os.path.exists(\"vectors.npy\") and os.path.exists(\"vectors.md5\"):\n",
        "    with open(\"vectors.md5\", \"r\") as f:\n",
        "        saved_md5 = f.read().strip()\n",
        "    if saved_md5 == json_md5:\n",
        "        print(\"✅ Loaded cached vectors.\")\n",
        "        vectors = np.load(\"vectors.npy\")\n",
        "    else:\n",
        "        print(\"🔄 Manual updated. Recomputing vectors...\")\n",
        "        vectors = embed_chunks(chunks)\n",
        "        np.save(\"vectors.npy\", vectors)\n",
        "        with open(\"vectors.md5\", \"w\") as f:\n",
        "            f.write(json_md5)\n",
        "else:\n",
        "    print(\"🔄 No cached vectors found. Computing now...\")\n",
        "    vectors = embed_chunks(chunks)\n",
        "    np.save(\"vectors.npy\", vectors)\n",
        "    with open(\"vectors.md5\", \"w\") as f:\n",
        "        f.write(json_md5)\n",
        "\n",
        "# ✅ Build FAISS index\n",
        "def build_faiss_index(vectors):\n",
        "    dim = vectors.shape[1]\n",
        "    index = faiss.IndexFlatL2(dim)\n",
        "    index.add(vectors)\n",
        "    return index\n",
        "\n",
        "index = build_faiss_index(vectors)\n",
        "\n",
        "# ✅ Search and return top_k results with similarity score\n",
        "def search(query, index, chunks, top_k=8):\n",
        "    query_vector = get_embedding(query)\n",
        "    D, I = index.search(np.array([query_vector]), top_k)\n",
        "    results = []\n",
        "    for i, idx in enumerate(I[0]):\n",
        "        chunk = chunks[idx]\n",
        "        chunk[\"similarity_score\"] = float(D[0][i])\n",
        "        results.append(chunk)\n",
        "    return results\n",
        "\n",
        "# Call GPT-4o\n",
        "def ask_gpt4o(context_texts, query):\n",
        "    # Join context content\n",
        "    context = \"\\n\\n\".join([\n",
        "        f\"Section: {c['metadata'].get('headings', 'Unknown')}\\n\\n{c['text']}\" for c in context_texts\n",
        "    ])\n",
        "\n",
        "    # New prompt: clearer structure and smarter instructions\n",
        "    prompt = f\"\"\"\n",
        "You are a clinical decision support assistant. Use only the content from the provided CANMAT clinical manual to answer the user's question.\n",
        "\n",
        "Instructions:\n",
        "- Carefully review the retrieved text and find any relevant medication recommendations, treatment considerations, or patient-specific factors.\n",
        "- If multiple options exist, summarize the top 1–2 and explain briefly why they are preferred.\n",
        "- Reference the section title or context when applicable.\n",
        "- If there is no explicit answer, you may reasonably infer from related sections (e.g. similar symptoms, comorbidities, or past treatments), but make that clear.\n",
        "- If absolutely no relevant information is available in the manual, respond with: \"No clear recommendation found in the manual.\"\n",
        "\n",
        "Please answer in 3–4 sentences using clear and clinically relevant language.\n",
        "\n",
        "---\n",
        "Clinical Manual:\n",
        "{context}\n",
        "\n",
        "Question:\n",
        "{query}\n",
        "\n",
        "Answer:\n",
        "\"\"\"\n",
        "\n",
        "    # Call GPT-4o API\n",
        "    response = client.chat.completions.create(\n",
        "        model=\"gpt-4o\",\n",
        "        messages=[\n",
        "            {\n",
        "                \"role\": \"system\",\n",
        "                \"content\": \"You are a medical assistant trained to follow evidence-based clinical guidelines only.\"\n",
        "            },\n",
        "            {\n",
        "                \"role\": \"user\",\n",
        "                \"content\": prompt\n",
        "            }\n",
        "        ],\n",
        "        temperature=0.2,\n",
        "        max_tokens=512\n",
        "    )\n",
        "\n",
        "    return response.choices[0].message.content.strip()\n",
        "\n",
        "# ✅ Test question list\n",
        "queries = [\n",
        "    \"I have a patient who can’t take lithium but is currently acutely manic. Which medication should I try next?\",\n",
        "    \"My patient with BDI-Depression had side effects from quetiapine. Which medication should I try next?\",\n",
        "    \"I have a patient experiencing hypomania and symptoms of depression. What is the recommended treatment?\",\n",
        "    \"My patient with Bipolar II disorder is acutely depressed. What medication should I try?\",\n",
        "    \"My patient with BDII will not adhere to any treatment plan that causes weight gain. How should I treat his depression?\",\n",
        "    \"My patient responded well to divalproex for acute mania in the past, but is now pregnant. How should I treat her?\",\n",
        "    \"My patient with Type 1 Bipolar and comorbid diabetes is experiencing depression. What is the recommended treatment?\",\n",
        "    \"My patient has hepatic dysfunction and is hypomanic. What is the recommended treatment?\",\n",
        "    \"My patient with Type 1 Bipolar and cardiovascular disease is experiencing depression. What is the recommended treatment?\",\n",
        "    \"I have a Bipolar Type II patient with renal disease who is experiencing depression. What is the recommended treatment?\",\n",
        "    \"My patient is experiencing their fourth episode of mania this year. How should I proceed?\",\n",
        "    \"I have a patient who is manic and experiencing psychotic features. I am considering the possibility of schizoaffective disorder. How should I proceed?\",\n",
        "    \"My patient is currently acutely depressed. He takes quetiapine for anti-manic prophylaxis, but it doesn't work for his depression. What should I try next?\",\n",
        "    \"My patient needs a quick treatment for their depression as they have pronounced suicidality. What should we use?\",\n",
        "    \"My patient with bipolar II responded well to lamotrigine in the past for acute depression. However, he was just admitted due to significant active suicidal ideation which I would like to treat as soon as possible. What should we use?\",\n",
        "    \"My patient is experiencing acute depression with anxious distress. Which first-line treatment should I choose?\",\n",
        "    \"I treated my patient's acute mania with lithium. How should I proceed with maintenance treatment?\",\n",
        "    \"I treated my patient's acute depression with quetiapine. How should I proceed with maintenance treatment?\",\n",
        "    \"What is the recommended maintenance treatment for my patient with BDII, if depression was treated with quetiapine?\",\n",
        "    \"I'm about to start treating a patient with lithium, what are common side effects at the start?\"\n",
        "]\n",
        "\n",
        "# ✅ Main loop: retrieval + print chunks + GPT call\n",
        "for i, q in enumerate(queries, 1):\n",
        "    retrieved_chunks = search(q, index, chunks)\n",
        "    print(f\"\\n🟦 QUESTION {i}: {q}\")\n",
        "    #print(f\"🔎 Retrieved Chunks:\")\n",
        "    for j, c in enumerate(retrieved_chunks, 1):\n",
        "        title = c[\"metadata\"].get(\"headings\", \"No heading\")\n",
        "        preview = c[\"text\"][:300].replace(\"\\n\", \" \")\n",
        "        score = round(c.get(\"similarity_score\", 0.0), 2)\n",
        "        #print(f\"-- Chunk {j} -- [Section: {title}] [Score: {score}]\\n{preview}...\\n\")\n",
        "\n",
        "    answer = ask_gpt4o(retrieved_chunks, q)\n",
        "    print(f\"\\n🤖 GPT-4o Answer:\\n{answer}\")\n"
      ]
    }
  ],
  "metadata": {
    "accelerator": "GPU",
    "colab": {
      "gpuType": "L4",
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}
